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We present an exceptional case of a giant urachal tumor, consisting of both villous adenoma and mucinous adenocarcinoma of
the urachus. The tumor was incidentally discovered during investigations for renal failure. Initial transurethral biopsies showed
only a villous adenoma of the urachus. Although the biopsies showed no malignancy, a radical cystoprostatectomy and broad
excision of the urachus and umbilicus were performed. At the same time, a bilateral nephroureterectomy was performed because
of reﬂux-nephropathy and renal failure. The indication for surgery was based on the typical imaging aspects, raising the suspicion
of an underlying urachal adenocarcinoma (size and location). Indeed, at ﬁnal histopathology a concomitant well-diﬀerentiated
adenocarcinoma of the urachus conﬁned to the urachal mucosa was found. The patient remained free of disease for 50 months of
follow-up. Only three previous cases of urachal adenocarcinoma associated with villous adenoma have been described.
Copyright © 2009 Steven Joniau et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1.Introduction
Primary adenocarcinoma of the bladder arises from the
urachal remnants or from the bladder urothelium. This
entity represents no more than 0.5%–2% of all malig-
nant bladder tumors. Urachal adenocarcinoma is extremely
uncommon and accounts for 0.11%–0.34% of all bladder
tumors. Intestinal metaplasia of the urachal epithelium is
the most frequent mechanism accounting for the majority
of adenocarcinomas of the urachus. Tumors of the urachal
remnant originate from the juxtavesical segment of the
urachus.Whilegrowing,theystarttoprotrudeinthebladder
dome. Most frequently, they present with haematuria, pain,
irritative voiding symptoms, and a lower midline abdominal
mass. In some patients, mucousuria may be within the
presenting symptoms [1, 2].
A urachal tumor is prone to extravesical growth and
has a poor prognosis [3]. Radical or partial cystectomy is
the treatment of choice, including wide resection of the
umbilicus and the urachal tumor [1, 3].
Villousadenomaisnotfrequentlyfoundoutsidethelarge
bowel. In the literature, less than 30 cases of villous adenoma
of the urachus have been described [4–7]. We describe a
case of a urachal adenocarcinoma arising within in a villous
adenoma of the bladder. Only three similar cases have been
described in the literature [8–10].
2.CaseReport
A 60-year-old man was referred to our institution because of
a sudden decline in renal function. He had a medical history
of chronic renal failure as a result of bilateral vesicoureteral
reﬂuxnephropathy.Apartfromnocturiaandurgency,hehad
no complaints. Physical examination was unremarkable. Lab
results revealed a serum Creatinin of 4.19mg/dL, a Creatinin
c l e a r a n c eo f2 2 m L / m i n ,a n dap r o t e i n u r i ao f3 . 4 8 g / 2 4 h .
Urinalysis showed no abnormalities. An abdominal ultra-
sound showed a polypoid, irregular mass, almost completely
replacing the bladder lumen. A cystoscopy demonstrated a
mucinous, nearly transparent bladder mass with prominent
exophytic growth, which inserted at the dome of the bladder.
Transurethral tumor biopsies showed a villous adenoma.
Malignant cells could not be found in the biopsies. Because2 Case Reports in Medicine
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Figure 1: Contrast enhanced CT-scan of the abdomen (prone position), showing a large bladder mass, protruding the bladder and almost
completely ﬁlling up the bladder lumen.
of the tumor size, no attempt was made to endoscopically
resect the tumor. A subsequent CT-scan of the abdomen
and pelvis conﬁrmed a tumoral mass originating from the
bladder dome. No invasion of the perivesical tissue was
noticed (Figure 1).
No pelvic or abdominal adenopathies were found.
Both kidneys showed extensive cortical damage, with loss
of nearly all the cortex of the right kidney. There was
a prominent bilateral hydro-ureteronephrosis. The size
and location of the tumor raised the suspicion for an
underlying urachal adenocarcinoma, although no malignant
cells were found in the biopsies. Since the kidney func-
tion was rapidly deteriorating and both kidneys showed
extensive cortical loss, we decided to perform a radical
cystoprostatectomy with bilateral nephroureterectomy. A
urinary conduit was installed in view of a future renal
transplant.
The postoperative course was uneventful. The patient
was started on haemodialysis. He was discharged from our
hospitals two weeks after the operation and has been without
disease recurrence for 50 months.
3.Histopathology
Macroscopic examination showed the presence of a muci-
nous mass with a ﬁbrous stalk of 2.5cm emerging from
the bladder dome, identiﬁed as being the urachus. The
mass weighed 40gr and was 16cm long. In the centre of
the mass, cysts ﬁlled with mucin were discovered. They
were lined with urachal mucinous adenocarcinoma with
beginning invasionintotheunderlyingbladderwall.Overall,
the diagnosis of a well-diﬀerentiated adenocarcinoma of the
urachus, conﬁned to the urachal mucosa (Sheldon stage I),
was made [1]. Nearby, villous adenoma of the bladder was
seen, appearing as complex branching papillary structures
lined by a pseudostratiﬁed mucinous epithelium. (Figures
2(a)–2(d)).
4. Discussion
The urachus is a vestigial remnant of the allantois that
normally obliterates during the descent of the bladder into
the pelvis [1]. These urachal remnants are the source ofCase Reports in Medicine 3
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Figure 2: (a) Villous adenoma of the bladder with complex branching papillary structures, that are distended due to the presence of the
exophytic mass in the lumen. There is no invasion into the underlying bladder wall ‘ (Hematoxylin Eosin stain, original magniﬁcation
50×) Inset: Higher magniﬁcation shows that the ﬁbrovascular stalks of the adenoma are lined by pseudostratiﬁed mucinous epithelium
with only mild degree of anisokaryosis. (Hematoxylin Eosin stain, original magniﬁcation 200×), (b) Urachal mucinous adenocarcinoma
characterized by small sheets and nests of columnar mucinous cells ﬂoating in extracellular mucin. (Hematoxylin Eosin stain, original
magniﬁcation 50×), (c) The cysts are lined with urachal mucinous adenocarcinoma with invasion in the bladder wall. (Hematoxylin Eosin
stain,originalmagniﬁcation25×),(d)Detailofpapillaryprojectionscoatedwithcolumnarmucinouscellswithpseudostratiﬁcation,nuclear
hyperchromasia and crowding, and goblet cells. (Hematoxylin Eosin stain, original magniﬁcation 200×).
glandular epithelium, derived by metaplasia according to the
totipotent cell theory of Mostoﬁ et al., and can undergo
malignant transformation [2].
Urachal neoplasms can be benign (adenoma) or malig-
nant. The benign adenomas are cystic tumors lined by
mucussecretingcolonicorrectaltypeepithelium[4].Villous
adenomas have been reported as papillary enteric adenoma
or villous tumor. The origin may be from the urachus
or caused by chronic irritation. Villous adenomas of the
bladder are rare with less than 30 cases described [4–10].
Some cases were coincident with cystitis glandularis, or
with adenocarcinoma, or with squamous cell carcinoma.
The mean age at presentation was ≈65 years. There seems
to be a link between villous adenomas, chronic irritation,
and cystitis glandularis [7]. Expression of p53 in villous
adenoma, but not in areas of cystitis glandularis, suggests
that genetic progression along the lines of the colonic
adenoma-carcinoma sequence may be responsible for the
development of villous adenoma in the bladder. A thorough
follow-up of all patients is recommended, considering that
this condition may be premalignant [6–10]. The present case
indeed clearly shows that a villous adenoma can further
develop to an adenocarcinoma, and allows us to better
understand the premalignant potential of such lesions.
Urachal malignant tumors have been classiﬁed as mucin-
positive adenocarcinoma (69%), mucin-negative adenocar-
cinoma (15%), sarcoma (8%), squamous cell cancer (3%),
transitional cell carcinoma (3%), and others (2%) [1]. A
urachal malignant tumor tends to occur at the junction
of the urachus and the bladder. The origin in the bladder
dome, the presence of an urachal remnant, the sharp
demarcation between tumor and normal urothelium, and
the absence of cystitis glandularis and cystitis cystica (which
can predispose to primary adenocarcinoma of the bladder)
are the diagnostic criteria for a urachal remnant carcinoma
[2, 3].
The majority of the urachal adenocarcinomas occur in
the ﬁfth and sixth decades, with a male/female ratio of
2.8/1. Haematuria, mucousuria, suprapubic pain or mass
are frequently mentioned as ﬁrst symptoms. Nevertheless,
symptoms may be nonspeciﬁc irritative urinary symptoms.
Whenever a bladder dome lesion presents with haematuria
or mucousuria, a urachal adenocarcinoma must be consid-
ered, even if transurethral biopsies show no malignancy as in
the presented case. A palpable midline infraumbilical mass
on clinical examination is uncommon.
Diagnosis is mainly based on imaging and cystoscopy.
Abdominal ultrasound may demonstrate a mass lesion in4 Case Reports in Medicine
the dome of the bladder. CT-scan is the most sensitive
imaging tool in diagnosing and staging of urachal tumors.
It allows evaluation of local tumor extension and of local and
distant lymph node involvement. Urinalysis usually reveals
haematuria, pyuria, and mucousuria. Urine cytology has a
high incidence of false negative results. A cystoscopy with or
without tumor biopsy will usually provide the ﬁnal diagnosis
of the presence of a dome lesion but will give no information
on the degree of malignancy of the lesion.
The treatment of urachal adenocarcinoma is still subject
to debate. The number of patients reported in the literature
is small and the biologic behaviour of these tumors still
remains ill deﬁned. Radical or partial cystectomy, both with
broad excision of the umbilicus and urachal remnant, is
the treatment of choice [1, 3]. Outcome seems to be more
related to the stage of the disease than to the extent of
the surgery. Less aggressive surgery can be recommended
for well-diﬀerentiated colonic-type tumors. Without bladder
epithelium invasion, urachal tumors usually tend to grow
towards the bladder lumen and leave a sharp demarcation
between tumor and normal bladder wall, thus allowing
resection of the tumor with a broad margin of normal
bladder tissue [3]. Sheldon et al. showed good results with
combined extended partial cystectomy and urachectomy for
well-selected patients [1].
Once a urachal tumor grows extra-vesically, it has a poor
prognosis. Local recurrences generally cause death despite
of salvage procedures [3]. Recurrence is usually seen in the
ﬁrst two postoperative years. The most common sites of
recurrence are the pelvis, the bladder, the wound, or the
abdominal wall [1].
In the present case, urachal adenocarcinoma was coex-
istent with villous adenoma, adding evidence to the theory
that adenocarcinoma can develop along the adenoma-
villous adenoma-adenocarcinoma line. To the best of our
knowledge, only 3 cases of coexistent villous adenoma and
adenocarcinoma of the urachus have been described so far
[8–10].Villousadenomaoftheurachusshouldbeconsidered
a premalignant lesion and should be treated aggressively.
5.Synopsis
Adenocarcinoma of the urachus is an infrequent, but very
aggressive type of bladder cancer. In localized disease,
surgery is the mainstay of treatment. Less is known about
precursors of this aggressive cancer. Villous adenoma is
a well-recognized premalignant lesion in the colon. We
provideevidencethatthissamelesion,iforiginatingfromthe
urachus,canbeconsideredaprecursorofadenocarcinomaof
the urachus, and should be treated aggressively.
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